Article Sidebar
Views PDF: 236
AN APPROACH TO DIAGNOSIS AND TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN THE OBESE
Main Article Content
Abstract
Background: Obstructive sleep apnea is a common respiratory disorder related to sleep, often coexisting with cardiovascular and metabolic diseases. Obese adults have a 45% incidence of obstructive sleep apnea, which can have negative effects on the cardiovascular system and potentially result in premature death. Content: Obstructive sleep apnea is characterized by apnea or hypopnea with decreased oxygen saturation or decreased arousal during sleep, leading to sleep fragmentation and increased proinflammatory factors. The diagnostic criteria is the apneahypopnea index (AHI) ≥ 5/hour when measured by type 1 polysomnography. Obesity is a condition of excessive increase in fat mass due to nutritional and metabolic disorders, determined by a body mass index ≥ 25 kg/m2. Obesity aggravates obstructive sleep apnea by influencing upper airway collapse through mechanical or neuromuscular mechanisms. On the contrary, obstructive sleep apnea also promotes obesity due to reduced physical activity and energy metabolism. Screening for obstructive sleep apnea in obese people can be conducted through questionnaires such as Epworth, Berlin, and STOP-BANG, or simpler polygraph techniques such as type 3 or type 4. Measuring and monitoring the carbon dioxide levels in exhaled breath is also considered in the approach to diagnosing obstructive sleep apnea in obese people. Treatment of obstructive sleep apnea in obese people includes postural treatment, losing weight through lifestyle changes, medication, surgery, and continuous positive airway pressure (CPAP). Conclusions: Obesity and obstructive sleep apnea are two disorders that interact. Obese individuals' screening results and polysomnography type 3 or type 4 can be used to diagnose OSA. A variety of approaches should be used to treat OSA in obese patients, including changes in sleeping posture, weight loss, and the addition of continuous positive pressure ventilation.
Article Details
Keywords
Obstructive sleep apnea, obesity, metabolic disorder
References
2. Romero-Corral A. and et al, Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest, 2010. 137(3): p. 711-719, doi: 10.1378/chest.09-0360.
3. Sankri-Tarbichi, A.G., Obstructive sleep apnea-hypopnea syndrome: Etiology and diagnosis. Avicenna Journal of Medicine, 2012. 2(01): p. 3-8, doi: 10.4103/2231-0770.94803.
4. Benjafield, A.V., et al., Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet Respiratory Medicine, 2019. 7(8): p. 687-698, doi: 10.1016/S2213-2600(19)30198-5.
5. Slowik, J.M., A. Sankari, and J.F. Collen, Obstructive Sleep Apnea. USA: StatPearls. 2022.
6. Punjabi, N.M., The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society, 2008. 5(2): p. 136-143, doi: 10.1513/pats.200709-155MG.
7. Cruz, I.A., M. Drummond, and J.C. Winck, Obstructive sleep apnea symptoms beyond sleepiness and snoring: effects of nasal APAP therapy. Sleep and Breathing, 2012. 16: p. 361366, doi: 10.1007/s11325-011-0502-4.
8. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị bệnh Nội tiết - Chuyển hóa. Hà Nội. 2015.
9. WHO, The Asia - Pacific perspective: Redefining obesity and its treament. 2000.
10. Schwartz, M.W., et al., Obesity pathogenesis: an endocrine society scientific statement. Endocrine reviews, 2017. 38(4): p. 267-296, https://doi.org/10.1210/er.2017-00111.
11. Lin, X. and H. Li, Obesity: epidemiology, pathophysiology, and therapeutics. Frontiers in endocrinology, 2021. 12: p. 706978, doi: 10.3389/fendo.2021.706978.
12. Flier, J.S., What’s in a name? In search of leptin’s physiologic role. The journal of clinical endocrinology & metabolism, 1998. 83(5): p. 1407-1413, doi: 10.1210/jcem.83.5.4779.
13. Farooqi, I.S., et al., Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England journal of medicine, 1999. 341(12): p. 879-884, doi: 10.1056/NEJM199909163411204.
14. Farooqi, I. and S. O Rahilly, Monogenic human obesity syndromes. Recent progress in hormone research, 2004. 59: p. 409-424, doi: 10.1210/rp.59.1.409.
15. Shah, N. and F. Roux, The Relationship of Obesity and Obstructive Sleep Apnea. Clin Chest Med, 2009: p. p.455–465, doi: 10.1016/j.ccm.2009.05.012.
16. Schwartz, A.R., et al., Obesity and Obstructive Sleep Apnea: Pathogenic Mechanisms and Therapeutic Approaches. Proc Am Thorac Soc, 2008. 5: p. p.185–192, doi: 10.1513/pats.200708-137MG.
17. Seetho, I.W. and J.P.H. Wilding, Screening for obstructive sleep apnoea in obesity and diabetes – potential for future approaches. Eur J Clin Invest, 2013. 43(6): p. 640–655, doi:
10.1111/eci.12083.
18. Fredheim, J.M., J. Røislien, and J. Hjelmesæth, Validation of a Portable Monitor for the Diagnosis of Obstructive Sleep Apnea in Morbidly Obese Patients. Journal of Clinical Sleep Medicine, 2014. 10(7): p. 751-757, doi: 10.5664/jcsm.3864.
19. Dumitrache-Rujinski, S., et al., The Role of Overnight PulseOximetry in Recognition of Obstructive Sleep Apnea Syndrome in Morbidly Obese and Non Obese Patients. MAEDICA – a Journal of Clinical Medicine, 2013. 8(3): p. 237-242, PMCID: PMC3869111.
20. Perger, E., et al., Diagnostic approach to sleep disordered-breathing among patients with grade III obesity. Sleep Medicine, 2021. 82: p. 18-22, doi: 10.1016/j.sleep.2021.03.024.
21. Eiseman, N.A., et al., The Impact of Body Posture and Sleep Stages on Sleep Apnea Severity in Adults. Journal of Clinical Sleep Medicine, 2012. 8(6): p. 655-666, PMID: 23243399.
22. Akita, Y., K. Kawakatsu, and C. Hattori, Posture of patients with sleep apnea during sleep. Acta Otolaryngol Supp, 2003. 550: p. 41-45, doi: 10.1080/0365523031000062.
23. A.Skinner, M., et al., Efficacy of the ‘tennis ball technique’ versus nCPAP in the management of position-dependent obstructive sleep apnoea syndrome. Respirology, 2008. 13(5): p. 708-715, doi: 10.1111/j.1440-1843.2008.01328.x.
24. Hamilton, G.S. and S.A. Joosten, Obstructive sleep apnoea and obesity. Aust Fam Physician, 2017. 46(7): p. 460-463, PMID: 28697288.
25. Kuna, S.T., D.M. Reboussin, and E.S. Strotmeyer, Effects of Weight Loss on Obstructive Sleep Apnea Severity: Ten-Year Results of the Sleep AHEAD Study. Am J Respir Crit Care Med, 2021. 203(2): p. 221–229, doi: 10.1164/rccm.201912-2511OC.
26. I, H.P., et al., Lifestyle Intervention with Weight Reduction: First-line Treatment in Mild Obstructive Sleep Apnea. Am J Respir Crit Care Med, 2009. 179: p. 320–327, doi:
10.1164/rccm.200805-669OC.
27. Ryan, D.H. and S.R. Yockey, Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr Obes Rep, 2017. 6(2): 187-194, doi: 10.1007/s13679-017-0262y.
28. Alruwaili, H., B. Dehestani, and C.W.l. Roux, Clinical Impact of Liraglutide as a Treatment of Obesity. Clinical Pharmacology: Advances and Applications, 2021. 13: p. 53–60, doi: 10.2147/CPAA.S276085.
29. A Romero-Corral and S.M. Caples, Interactions Between Obesity and Obstructive Sleep Apnea Implications for Treatment. CHEST, 2010. 137(3): p. 711-719, doi: 10.1378/chest.09-0360.
30. Garcia, J.M., et al., Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respiratory Research, 2011. 12:80, doi: 10.1186/1465-9921-12-80.
31. Coughlin, S.R., et al., Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J, 2007. 29: p. 720–727, doi: 10.1183/09031936.00043306.
32. O'Donnell, C., et al., Liraglutide-Based Weight Loss versus CPAP Therapy in improving Sleep Quality and Quality of Life of Patients with Obstructive Sleep Apnoea - an Explorative, Proof of Concept Study. ERJ Open Research, 2023. 9: p. 110, doi:
10.1183/23120541.sleepandbreathing-2023.110.
33. Chen, B., et al., Effect of Continuous Positive Airway Pressure on Weight and Local Adiposity in Adults with Obstructive Sleep Apnea: A Meta-Analysis. Ann Am Thorac Soc, 2021. 18(10): p. 1717–1727, https://doi.org/10.1513/AnnalsATS.202101-060OC.